Home Newsfeeds Baird Downgrades Maxar Technologies to Neutral, Raises Price Target to $53

Baird Downgrades Maxar Technologies to Neutral, Raises Price Target to $53

Baird analyst Peter Arment downgrades Maxar Technologies (NYSE:MAXR) from Outperform to Neutral and raises the price target from $45 to $53.

byBenzinga Newsdesk

December 19, 2022

1 minute read

Baird analyst Peter Arment downgrades Maxar Technologies (NYSE:MAXR) from Outperform to Neutral and raises the price target from $45 to $53.

What’s Going On With Motorsport Games Stock?

By Adam Eckert

February 1, 12:25 PM

Motorsport Games Inc (NASDAQ: MSGM) shares traded higher by more than 700% on Tuesday before adding a more than 200% gain in premarket trading Wednesday morning.

MSGM

FDA Okays bluebird bio’s $3M Gene Therapy For Rare Neurological Disorder In Boys: What Investors Should Know

By Shanthi Rexaline

September 17, 9:46 AM

Biotechnology company, bluebird bio, Inc. (NASDAQ: BLUE) announced late Friday that the Food and Drug Administration approved its gene therapy for a rare neurodegenerative disease.

BLUE

$100 Invested In American Water Works 10 Years Ago Would Be Worth This Much Today

By Benzinga Insights

August 15, 10:15 AM

American Water Works (NYSE:AWK) has outperformed the market over the past 10 years by 3.99% on an annualized basis producing an average annual return of 15.6%. Currently, American Water Works has a market capitalization of $28.86 billion.

AWK

JD.Com’s Cost Management In Focus – Analyst Maintains Core GMV Growth Assumptions

By Nabaparna Bhattacharya

April 16, 2:10 PM

Analyst maintains Buy rating on JD.com, anticipating core GMV growth and earnings upside from disciplined cost management amidst healthy China retail/e-commerce growth.

Baird Downgrades Maxar Technologies to Neutral, Raises Price Target to $53

Related Posts

What’s Going On With Motorsport Games Stock?

FDA Okays bluebird bio’s $3M Gene Therapy For Rare Neurological Disorder In Boys: What Investors Should Know

$100 Invested In American Water Works 10 Years Ago Would Be Worth This Much Today

JD.Com’s Cost Management In Focus – Analyst Maintains Core GMV Growth Assumptions